Biosimilar Drugs

Biosimilar drugs are cost-effective, “highly similar” copies of brand-name biological drugs whose patents have expired. Health Canada reviews and approves biosimilars to ensure their safety and effectiveness.

The Alberta government’s Biosimilars Initiative requires the replacement of some brand name drugs with biosimilar drugs, when possible. This required change only applies if adult patients (those over 18 and not pregnant) have coverage under an Alberta government sponsored drug plan.

This change won’t affect your ASEBP benefits, at this time; however, if you have coverage under multiple plans, we encourage you to check what changes, if any, your other service provider may implement now or in the future. Other service providers are developing biosimilar strategies that may not align with ASEBP coverage, so it is important for ASEBP members to be well informed when using biological products to maximize coverage.

Visit the Government of Alberta’s Biosimilars Initiative for more information.

Placeholder - Image

We’d love to hear from you

Phone

Fax: 780-438-5304
Toll Free: 1-877-431-4786
Allendale Centre East
Suite 301, 6104-104 Street NW
Edmonton, AB T6H 2K7
 
Contact Centre Hours
Sept - June: 7:30 am – 5:00 pm
July - Aug: 8:30 am – 4:30 pm
 
Reception Hours
Open for scheduled meetings: 9:15 a.m. – 3 p.m.
(closed 12:15-12:45 p.m.)
Monday to Friday
© 2022 ASEBP. All right reserved.
crosschevron-down